https://clinicaltrials.gov/ct2/show/NCT01206062
ニュースリリース
http://www.nih.gov/news/health/sep2015/nhlbi-11.htm
50歳以上の心疾患高リスクあるいは腎疾患を有する対象者に、収縮期血圧 120mm水銀柱を維持目標値にする、より強化維持目標介入トライアル
2009年秋から開始、50歳以上9300名超の被験者、約100のメディカルセンターで登録
2010年から2013年、目標値を2つに分けて、収縮期血圧 140mm水銀柱未満と上記120mm水銀柱未満に分けてコントロール
解説原文
“Our results provide important evidence that treating blood pressure to a lower goal in older or high-risk patients can be beneficial and yield better health results overall,” said Lawrence Fine, M.D., chief, Clinical Applications and Prevention Branch at NHLBI. “But patients should talk to their doctor to determine whether this lower goal is best for their individual care.”
50歳以上の高齢者でベネフィット認め、包括的に良好な結果だったそうな
The study is also examining kidney disease, cognitive function, and dementia among the patients; however, those results are still under analysis and are not yet available as additional information will be collected over the next year. The primary results of the trial will be published within the next few months.腎疾患、認知機能、認知症への検討がなされ、今後報告される
論文発表が待たれる
